Product Description
361442-04-8 Saxagliptin API refers to the active pharmaceutical ingredient (API) of the medication saxagliptin. It is used in the management of type 2 diabetes mellitus. This works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Saxagliptin is an oral antidiabetic medication belonging to the class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Moreover,m 361442-04-8 Saxagliptin API undergoes stringent quality control measures to ensure its purity, potency, and safety before being formulated into finished pharmaceutical products.